YHLO (EST. 2008) is an innovative and steadfastly growing company headquartered in Shenzhen, China.
To be a reliable and respected IVD enterprise, with continuous development expertise in immunoassays solution, YHLO may provide a broad range of instruments (based on CLIA, ELISA, Immunoblot and IFA methodologies) with outstanding features, as well as a comprehensive total solutions with portfolios in fertility, diabetes, infectious diseases, autoimmune disorders and other novel assays on rare diseases analysis.
YHLO thanks to its premium quality management has been certified by international standards, ISO 9001:2008, ISO 13485:2012, KGMP of Korea, TGA of Australia, etc. To date, YHLO has a global presence by nearly 100 countries around the world. Moreover, YHLO has in-depth cooperation with oversea research partners worldwide, with aim of developing advanced technologies and create more medical value for health and vitality of people all over the world.